MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

06 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 205.58 millions rose by 33.75% from Rs. 153.70 millions.A comparatively good net profit growth of 26.74% to Rs. 38.39 millions was reported for the quarter ended March 2022 compared to Rs. 30.29 millions of previous same quarter.Operating profit for the quarter ended March 2022 rose to 57.83 millions as compared to 52.39 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 205.58 153.70 33.75 712.88 490.82 45.24 712.88 490.82 45.24
Other Income 11.37 1.53 643.14 35.68 20.95 70.31 35.68 20.95 70.31
PBIDT 57.83 52.39 10.38 214.88 157.42 36.50 214.88 157.42 36.50
Interest 0.15 0.14 7.14 1.46 0.68 114.71 1.46 0.68 114.71
PBDT 57.68 52.25 10.39 213.42 156.74 36.16 213.42 156.74 36.16
Depreciation 5.80 11.84 -51.01 33.37 27.25 22.46 33.37 27.25 22.46
PBT 51.88 40.41 28.38 180.05 129.49 39.05 180.05 129.49 39.05
TAX 13.49 10.12 33.30 46.07 31.96 44.15 46.07 31.96 44.15
Deferred Tax -0.03 -3.18 -99.06 -0.39 -0.36 8.33 -0.39 -0.36 8.33
PAT 38.39 30.29 26.74 133.98 97.53 37.37 133.98 97.53 37.37
Equity 120.08 100.06 20.01 120.08 100.06 20.01 120.08 100.06 20.01
PBIDTM(%) 28.13 34.09 -17.47 30.14 32.07 -6.02 30.14 32.07 -6.02
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..